Double maintains 1 strategies that include NRIX - Nurix Therapeutics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GORV | -0.13% | $27.07M | -91.17% | 0.00% |
KR | 0.14% | $46.43B | +38.38% | 1.85% |
CREG | -0.19% | $5.77M | -79.16% | 0.00% |
LTM | -0.21% | $12.63B | -95.46% | 2.42% |
GFI | 0.23% | $21.56B | +57.55% | 2.31% |
CPSH | -0.59% | $42.27M | +74.25% | 0.00% |
MCK | -0.59% | $88.11B | +20.93% | 0.40% |
MNOV | -0.60% | $62.29M | -9.29% | 0.00% |
STG | -0.61% | $30.78M | -22.51% | 0.00% |
CCRN | 0.72% | $429.13M | -3.89% | 0.00% |
MDLZ | 0.86% | $90.07B | +4.85% | 2.72% |
K | 0.88% | $27.76B | +41.17% | 2.85% |
EXC | -0.88% | $43.33B | +23.58% | 3.62% |
AQB | 0.98% | $2.96M | -53.35% | 0.00% |
LRN | 0.99% | $5.99B | +100.06% | 0.00% |
BTCT | 1.00% | $25.56M | +61.14% | 0.00% |
DFDV | 1.11% | $300.56M | +2,130.16% | 0.00% |
DAO | 1.28% | $262.76M | +119.32% | 0.00% |
AEP | -1.29% | $55.16B | +17.93% | 3.54% |
HUSA | 1.37% | $19.66M | -19.53% | 0.00% |
Current Value
$12.461 Year Return
Current Value
$12.461 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -16.97% | $24.23B | +35.36% | 1.09% |
CME | -12.32% | $99.39B | +40.68% | 3.86% |
T | -9.07% | $203.71B | +51.55% | 3.92% |
ED | -7.22% | $36.00B | +12.64% | 3.34% |
VSTA | -7.00% | $344.07M | +39.29% | 0.00% |
VZ | -6.18% | $183.79B | +6.01% | 6.18% |
ZCMD | -6.07% | $29.55M | -8.59% | 0.00% |
VSA | -5.30% | $8.67M | -19.04% | 0.00% |
KMB | -5.11% | $43.92B | -3.75% | 3.75% |
NOC | -5.10% | $71.81B | +14.14% | 1.69% |
AMT | -4.91% | $104.32B | +14.40% | 3.00% |
VHC | -4.66% | $48.19M | +108.24% | 0.00% |
CNC | -4.54% | $16.81B | -49.40% | 0.00% |
TEF | -4.33% | $30.08B | +25.41% | 6.16% |
NEUE | -3.76% | $61.24M | +29.92% | 0.00% |
AWK | -3.56% | $27.36B | +9.65% | 2.21% |
AIFU | -3.49% | $6.79B | +102.19% | 0.00% |
CYCN | -3.36% | $10.59M | +46.35% | 0.00% |
MKTX | -3.36% | $8.22B | +9.03% | 1.38% |
MO | -3.13% | $99.67B | +28.77% | 6.90% |
Yahoo
Immunome (IMNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Finnhub
Nurix Therapeutics, Inc. dropped from Russell Microcap Growth Index...
Finnhub
Nurix Therapeutics, Inc. dropped from Russell 3000E Growth Index...
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Finnhub
Nurix Therapeutics, Inc. dropped from Russell 2500 Growth Index...
Finnhub
Nurix Therapeutics, Inc. dropped from Russell 2000 Growth Index...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KYMR | 65.35% | $3.12B | +47.65% | 0.00% |
DNLI | 61.06% | $2.16B | -30.05% | 0.00% |
IDYA | 57.51% | $1.92B | -34.15% | 0.00% |
BEAM | 55.97% | $2.00B | -15.33% | 0.00% |
RNA | 55.07% | $3.54B | -21.10% | 0.00% |
OCUL | 53.33% | $1.51B | +41.41% | 0.00% |
CRNX | 52.73% | $2.76B | -33.39% | 0.00% |
XENE | 51.90% | $2.56B | -7.61% | 0.00% |
STOK | 51.01% | $630.59M | -8.84% | 0.00% |
SYRE | 50.98% | $935.48M | -39.83% | 0.00% |
IMNM | 50.78% | $750.92M | -28.80% | 0.00% |
ATXS | 50.27% | $323.37M | -36.33% | 0.00% |
RVMD | 50.09% | $6.93B | +0.73% | 0.00% |
ZYME | 49.91% | $905.57M | +53.64% | 0.00% |
RARE | 49.83% | $3.73B | -1.87% | 0.00% |
APGE | 49.61% | $2.64B | +18.19% | 0.00% |
SNDX | 49.24% | $774.43M | -55.18% | 0.00% |
CGON | 49.23% | $2.03B | -13.46% | 0.00% |
DYN | 49.06% | $1.02B | -73.78% | 0.00% |
CLDX | 48.03% | $1.47B | -38.43% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -40.44% | $164.54M | 0.85% |
BTAL | -40.08% | $296.22M | 1.43% |
TAIL | -37.26% | $99.63M | 0.59% |
IVOL | -17.84% | $347.03M | 1.02% |
TBLL | -10.79% | $2.13B | 0.08% |
XONE | -10.52% | $625.28M | 0.03% |
TPMN | -10.48% | $30.70M | 0.65% |
ULST | -10.46% | $654.75M | 0.2% |
FXY | -10.29% | $816.38M | 0.4% |
JMST | -9.94% | $4.06B | 0.18% |
SPTS | -9.65% | $5.80B | 0.03% |
XHLF | -9.13% | $1.73B | 0.03% |
UTWO | -8.47% | $379.52M | 0.15% |
DFNM | -8.35% | $1.57B | 0.17% |
TFLO | -7.78% | $6.82B | 0.15% |
SCHO | -7.54% | $11.03B | 0.03% |
CANE | -6.97% | $10.37M | 0.29% |
FTSD | -6.65% | $231.81M | 0.25% |
CLIP | -6.41% | $1.51B | 0.07% |
VGSH | -5.92% | $22.80B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 66.55% | $4.82B | 0.35% |
GNOM | 61.86% | $44.57M | 0.5% |
IBB | 60.59% | $5.26B | 0.45% |
ARKG | 58.54% | $1.02B | 0.75% |
PTH | 57.88% | $100.85M | 0.6% |
PBE | 57.64% | $223.19M | 0.58% |
XPH | 57.59% | $147.96M | 0.35% |
IWC | 54.09% | $818.14M | 0.6% |
FBT | 53.20% | $1.01B | 0.54% |
IWO | 53.14% | $11.60B | 0.24% |
PINK | 52.77% | $130.57M | 0.5% |
VTWO | 51.45% | $12.52B | 0.07% |
IWM | 51.44% | $63.72B | 0.19% |
BBH | 51.06% | $330.62M | 0.35% |
RDTE | 50.78% | $137.93M | 0.97% |
KJUL | 50.00% | $119.50M | 0.79% |
SCHA | 49.97% | $17.26B | 0.04% |
ISCG | 49.89% | $681.20M | 0.06% |
KJAN | 49.66% | $287.30M | 0.79% |
IWMY | 49.21% | $119.32M | 1.02% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BSV | 0.09% | $38.39B | 0.03% |
SPTI | 0.19% | $8.82B | 0.03% |
STIP | -0.19% | $12.72B | 0.03% |
SCHR | 0.19% | $10.92B | 0.03% |
CGMU | 0.21% | $3.36B | 0.27% |
SHY | -0.23% | $23.83B | 0.15% |
IBTL | 0.23% | $381.01M | 0.07% |
CMF | 0.24% | $3.59B | 0.08% |
STXT | 0.43% | $129.40M | 0.49% |
IBTM | 0.45% | $316.49M | 0.07% |
TAXF | 0.51% | $489.34M | 0.29% |
HYMB | -0.65% | $2.63B | 0.35% |
ICSH | 0.71% | $6.02B | 0.08% |
UTEN | 0.88% | $210.24M | 0.15% |
CORN | -0.89% | $44.67M | 0.2% |
IBMN | -0.93% | $447.08M | 0.18% |
GOVT | 0.95% | $27.54B | 0.05% |
IBTK | -0.95% | $448.89M | 0.07% |
GSST | -0.96% | $921.46M | 0.16% |
IBTO | 0.96% | $352.69M | 0.07% |